doTERRA   Report issue

For profit Phase 3
Founded: Pleasant Grove UT United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2017
NCT03093454
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

dōTERRA International

Active Ingredients

Drugs in Phase 3 Trials (1)

lavender (1 trial)

Drugs in Other Trials (1)

copaiba (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2